Literature DB >> 13596417

A comparative study of two regimens of combination chemotherapy in acute leukemia.

E FREI, J F HOLLAND, M A SCHNEIDERMAN, D PINKEL, G SELKIRK, E J FREIREICH, R T SILVER, G L GOLD, W REGELSON.   

Abstract

Entities:  

Keywords:  FOLIC ACID ANTAGONISTS/therapeutic use; LEUKEMIA/therapy; MERCAPTOPURINE/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13596417

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  28 in total

1.  Toxic complications of treatment with 6-mercaptopurine; two cases with hepatic necrosis and intestinal ulceration.

Authors:  P A CLARK; Y E HSIA; R G HUNTSMAN
Journal:  Br Med J       Date:  1960-02-06

2.  The NIH Clinical Center and the future of clinical research.

Authors:  John I Gallin
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

Review 3.  Understanding resistance to combination chemotherapy.

Authors:  Justin R Pritchard; Douglas A Lauffenburger; Michael T Hemann
Journal:  Drug Resist Updat       Date:  2012-11-17       Impact factor: 18.500

4.  Defining principles of combination drug mechanisms of action.

Authors:  Justin R Pritchard; Peter M Bruno; Luke A Gilbert; Kelsey L Capron; Douglas A Lauffenburger; Michael T Hemann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-18       Impact factor: 11.205

Review 5.  Chemotherapy of acute leukemia in childhood.

Authors:  K K Khanna
Journal:  Indian J Pediatr       Date:  1968-12       Impact factor: 1.967

6.  Multiclinic trials in cancer chemotherapy.

Authors:  C G Zubrod
Journal:  Can Med Assoc J       Date:  1967-07-15       Impact factor: 8.262

7.  Clinical trials in the era of personalized oncology.

Authors:  Michael L Maitland; Richard L Schilsky
Journal:  CA Cancer J Clin       Date:  2011-10-27       Impact factor: 508.702

8.  Optimum Induction Chemotherapy for Pediatric Acute Myeloid Leukemia: Experience From A Developing Country.

Authors:  Tariq Ghafoor; Shakeel Ahmed; Sumaira Khalil; Tanzeela Farah
Journal:  J Pediatr Pharmacol Ther       Date:  2020

Review 9.  Biology-driven cancer drug development: back to the future.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  BMC Biol       Date:  2010-04-12       Impact factor: 7.431

10.  Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

Authors:  Hélène Salmon; Juliana Idoyaga; Adeeb Rahman; Marylène Leboeuf; Romain Remark; Stefan Jordan; Maria Casanova-Acebes; Makhzuna Khudoynazarova; Judith Agudo; Navpreet Tung; Svetoslav Chakarov; Christina Rivera; Brandon Hogstad; Marcus Bosenberg; Daigo Hashimoto; Sacha Gnjatic; Nina Bhardwaj; Anna Karolina Palucka; Brian D Brown; Joshua Brody; Florent Ginhoux; Miriam Merad
Journal:  Immunity       Date:  2016-04-19       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.